Cargando…

Important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats

AIM/INTRODUCTION: Both glucocorticoids and 5‐hydroxytryptamine (5‐HT) have been shown to induce insulin resistance (IR) in hepatocytes and adipocytes. Here, we explore whether there is a correlation between them. MATERIALS AND METHODS: Except for the control group, male rats were exposed to dexameth...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tao, Guo, Keke, Qu, Wei, Han, Ying, Wang, Shanshan, Lin, Min, An, Shanshan, Li, Xin, Ma, Shaoxin, Wang, Tianying, Ji, Shiya, Hanson, Christian, Fu, Jihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718103/
https://www.ncbi.nlm.nih.gov/pubmed/26816599
http://dx.doi.org/10.1111/jdi.12406
_version_ 1782410739771768832
author Li, Tao
Guo, Keke
Qu, Wei
Han, Ying
Wang, Shanshan
Lin, Min
An, Shanshan
Li, Xin
Ma, Shaoxin
Wang, Tianying
Ji, Shiya
Hanson, Christian
Fu, Jihua
author_facet Li, Tao
Guo, Keke
Qu, Wei
Han, Ying
Wang, Shanshan
Lin, Min
An, Shanshan
Li, Xin
Ma, Shaoxin
Wang, Tianying
Ji, Shiya
Hanson, Christian
Fu, Jihua
author_sort Li, Tao
collection PubMed
description AIM/INTRODUCTION: Both glucocorticoids and 5‐hydroxytryptamine (5‐HT) have been shown to induce insulin resistance (IR) in hepatocytes and adipocytes. Here, we explore whether there is a correlation between them. MATERIALS AND METHODS: Except for the control group, male rats were exposed to dexamethasone treated with or without para‐chlorophenylalanine (pCPA), or carbidopa for 20 days. Except for the control group, buffalo rat liver 3A (BRL‐3A) cells were exposed to dexamethasone for 24 h, treated with or without pCPA, carbidopa, or clorgiline for 48 h, or exposed to 5‐HT treated with or without fluoxetine for 48 h. Whole‐body IR was determined by both glucose tolerance test and measurement of fasting blood glucose and insulin, whereas hepatocytes or adipocytes IR was determined by examining either hepatic gluconeogenesis, steatosis and glucose transporter 2 expression or lipolysis. RESULTS: Dexamethasone‐induced whole‐body IR, liver and intraabdominal adipose IR were accompanied by upregulated expressions of tryptophan hydroxylase‐1 and aromatic amino acid decarboxylase with increased 5‐HT level in both tissues, which were attenuated significantly by pCPA, inhibiting tryptophan hydroxylase‐1, or carbidopa, inhibiting aromatic amino acid decarboxylase. [Correction added on 22 September 2015, after first online publication: ‘inhibiting aromatic amino acid decarboxylase’ was duplicated and has been replaced by ‘tryptophan hydroxylase‐1’.] In the BRL‐3A cells, dexamethasone‐induced IR was also accompanied by upregulated 5‐HT synthesis in dose‐ and time‐dependent manners, and was attenuated by pCPA or carbidopa, but exacerbated by clorgiline, inhibiting monoamine oxidase‐A to further increase 5‐HT level. Dexamethasone also enhanced 5‐HT 2A and 2B receptor expressions in both tissues and BRL‐3A cells. Additionally, blocking 5‐HT transporter with fluoxetine significantly suppressed 5‐HT‐induced IR in BRL‐3A cells. CONCLUSION: Enhancement of 5‐HT synthesis in liver and intra‐abdominal adipose is an important reason for glucocorticoids‐induced IR.
format Online
Article
Text
id pubmed-4718103
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-47181032016-01-26 Important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats Li, Tao Guo, Keke Qu, Wei Han, Ying Wang, Shanshan Lin, Min An, Shanshan Li, Xin Ma, Shaoxin Wang, Tianying Ji, Shiya Hanson, Christian Fu, Jihua J Diabetes Investig Articles AIM/INTRODUCTION: Both glucocorticoids and 5‐hydroxytryptamine (5‐HT) have been shown to induce insulin resistance (IR) in hepatocytes and adipocytes. Here, we explore whether there is a correlation between them. MATERIALS AND METHODS: Except for the control group, male rats were exposed to dexamethasone treated with or without para‐chlorophenylalanine (pCPA), or carbidopa for 20 days. Except for the control group, buffalo rat liver 3A (BRL‐3A) cells were exposed to dexamethasone for 24 h, treated with or without pCPA, carbidopa, or clorgiline for 48 h, or exposed to 5‐HT treated with or without fluoxetine for 48 h. Whole‐body IR was determined by both glucose tolerance test and measurement of fasting blood glucose and insulin, whereas hepatocytes or adipocytes IR was determined by examining either hepatic gluconeogenesis, steatosis and glucose transporter 2 expression or lipolysis. RESULTS: Dexamethasone‐induced whole‐body IR, liver and intraabdominal adipose IR were accompanied by upregulated expressions of tryptophan hydroxylase‐1 and aromatic amino acid decarboxylase with increased 5‐HT level in both tissues, which were attenuated significantly by pCPA, inhibiting tryptophan hydroxylase‐1, or carbidopa, inhibiting aromatic amino acid decarboxylase. [Correction added on 22 September 2015, after first online publication: ‘inhibiting aromatic amino acid decarboxylase’ was duplicated and has been replaced by ‘tryptophan hydroxylase‐1’.] In the BRL‐3A cells, dexamethasone‐induced IR was also accompanied by upregulated 5‐HT synthesis in dose‐ and time‐dependent manners, and was attenuated by pCPA or carbidopa, but exacerbated by clorgiline, inhibiting monoamine oxidase‐A to further increase 5‐HT level. Dexamethasone also enhanced 5‐HT 2A and 2B receptor expressions in both tissues and BRL‐3A cells. Additionally, blocking 5‐HT transporter with fluoxetine significantly suppressed 5‐HT‐induced IR in BRL‐3A cells. CONCLUSION: Enhancement of 5‐HT synthesis in liver and intra‐abdominal adipose is an important reason for glucocorticoids‐induced IR. John Wiley and Sons Inc. 2015-09-13 2016-01 /pmc/articles/PMC4718103/ /pubmed/26816599 http://dx.doi.org/10.1111/jdi.12406 Text en © 2015 The Authors. Journal of Diabetes Investigation published by Asian Association of the Study of Diabetes (AASD) and Wiley Publishing Asia Pty Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Articles
Li, Tao
Guo, Keke
Qu, Wei
Han, Ying
Wang, Shanshan
Lin, Min
An, Shanshan
Li, Xin
Ma, Shaoxin
Wang, Tianying
Ji, Shiya
Hanson, Christian
Fu, Jihua
Important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats
title Important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats
title_full Important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats
title_fullStr Important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats
title_full_unstemmed Important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats
title_short Important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats
title_sort important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718103/
https://www.ncbi.nlm.nih.gov/pubmed/26816599
http://dx.doi.org/10.1111/jdi.12406
work_keys_str_mv AT litao importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats
AT guokeke importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats
AT quwei importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats
AT hanying importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats
AT wangshanshan importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats
AT linmin importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats
AT anshanshan importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats
AT lixin importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats
AT mashaoxin importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats
AT wangtianying importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats
AT jishiya importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats
AT hansonchristian importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats
AT fujihua importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats